Skip to main content

D. E. Shaw & Co., Inc.

Position in AVIR — Atea Pharmaceuticals, Inc.

CIK 1009207 New York, NY

Position in AVIR

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$1,605,114
-$435,594 QoQ
Shares Held
345,186
-9.0% QoQ
Ownership
0.430%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#23
of 124 holders
Holding Since
Mar 2021
18 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in AVIR Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

D. E. Shaw & Co., Inc. holds $5,017,559,982 across 217 Biotechnology names. AVIR ranks #138 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in AVIR

Export CSV
18 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,605,114 345,186
2026-03-31 $2,040,708 379,314
2025-12-31 $1,659,289 464,787
2025-09-30 $1,057,827 364,768
2025-06-30 $705,067 195,852
2025-03-31 $1,030,189 344,545
2024-12-31 $857,877 256,083
2024-09-30 $648,485 193,578
2024-06-30 $489,591 147,913
2024-03-31 $839,345 207,759
2023-12-31 $564,789 185,177
2023-09-30 $209,847 69,949
2023-06-30 $311,998 83,422
2023-03-31 $166,488 49,698
2022-12-31 $193,467 40,222
2022-09-30 $165,903 29,157
2021-12-31 $173,471 19,404
2021-03-31 $1,740,547 28,187